Episurf Medical

1,23SEK -3 %
1 investor følger denne virksomhed

Episurf Medical is a medical technology company. The company conducts research and development of products used for the treatment of cartilage damage. Episurf's primary focus is on the recovery of knee joints, but the company's implants can also be applied to other joints. Episurf Medical is in the preclinical verification phase and is headquartered in Stockholm.

Omsætning
6,6 mio.
EBIT %
-1.166,67 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
EPIS B
Daglig lav / høj pris
1,23 / 1,268 SEK
Markedsværdi
327,71 mio. SEK
Aktieomsætning
46,37 t SEK
Volumen
37 t

Finanskalender